Human Oligodendrocyte Myelination Potential; Relation to Age and Differentiation
Julia Xiao Xuan Luo1, Qiao-Ling Cui1, Moein Yaqubi1
1Neuroimmunology Unit, Montreal Neurological Institute and Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Annals of Neurology
|December 25, 2021
Summary
Human pediatric oligodendrocyte lineage cells show superior myelination potential compared to adult cells. These findings highlight age-related differences in myelin regeneration capacity and suggest therapeutic targets for central nervous system repair.
Area of Science:
- Neuroscience
- Cell Biology
- Regenerative Medicine
Background:
- Myelin regeneration in the central nervous system is crucial for recovery from demyelinating disorders like multiple sclerosis.
- Age and progenitor cell characteristics are known factors influencing remyelination efficiency.
Purpose of the Study:
- To investigate the impact of age and differentiation status on the myelination potential of human oligodendrocyte lineage cells.
- To compare the myelination capacity of pediatric versus adult oligodendrocyte progenitor cells and mature oligodendrocytes.
Main Methods:
- Primary oligodendrocyte lineage cells were isolated from pediatric and adult human brain tissue.
- Ensheathment capacity was assessed using nanofiber assays.
- Transcriptomic profiles were analyzed via RNA sequencing.
Main Results:
- Pediatric progenitor and mature cells demonstrated more robust nanofiber ensheathment than adult cells.
- A2B5+ progenitors exhibited greater ensheathment capacity than mature cells within both age groups.
- Gene expression analysis revealed higher levels of PDGFRA and PTPRZ1 in pediatric and progenitor cells, with upregulation of p38 MAP kinase and actin cytoskeleton pathways in pediatric cells.
Conclusions:
- Human pediatric oligodendrocyte lineage cells possess greater myelination potential compared to adult cells.
- Specific biological pathways influencing myelination are differentially expressed between pediatric and adult oligodendrocyte lineage cells.
- Findings suggest potential therapeutic targets for enhancing remyelination in demyelinating diseases.


